1.3K(top 0.1%)
papers
34.9K(top 0.1%)
citations
87(top 0.1%)
h-index
153(top 0.1%)
g-index
1.5K
all documents
37.4K
doc citations
3.7K
citing journals

Top Articles

#TitleJournalYearCitations
1Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trialLancet, The20131,490
2Comparison of Primary Coronary Angioplasty and Intravenous Thrombolytic Therapy for Acute Myocardial InfarctionJAMA - Journal of the American Medical Association1997796
3Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial FibrillationJAMA - Journal of the American Medical Association2014765
4Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score IILancet, The2013679
5A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarctionEuropean Heart Journal2006568
6Safety and Efficacy of the Totally Subcutaneous Implantable DefibrillatorJournal of the American College of Cardiology2015458
7Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD RegistryEuropean Heart Journal2014410
8Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registryEuropean Heart Journal2016410
9Primary Results From the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) TrialCirculation2010366
10Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trialHeart Rhythm2017331
11A Checklist for Retrospective Database Studies—Report of the ISPOR Task Force on Retrospective DatabasesValue in Health2003328
12Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial†European Journal of Cardio-thoracic Surgery2013317
13The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapyEuropean Heart Journal2011305
14Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survivalHeart Rhythm2011302
15Device-Related Thrombus After Left Atrial Appendage ClosureCirculation2018298
16Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trialEuropean Heart Journal2014292
17Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trialEuropean Heart Journal2015291
18Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthmaJournal of Allergy and Clinical Immunology2013288
19The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phaseAmerican Heart Journal2006281
20Development and Validation of a Novel Scoring System for Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary InterventionsJACC: Cardiovascular Interventions2016276
21Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery DiseaseJournal of the American College of Cardiology2010271
22Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator RegistryJournal of the American College of Cardiology2017266
23Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six monthsJournal of the American College of Cardiology2000265
24Heart Failure Decompensation and All-Cause Mortality in Relation to Percent Biventricular Pacing in Patients With Heart FailureJournal of the American College of Cardiology2009264
25The Negative Impact of Incomplete Angiographic Revascularization on Clinical Outcomes and Its Association With Total OcclusionsJournal of the American College of Cardiology2013257
26Medical applications of poly(styrene-block-isobutylene-block-styrene) (“SIBS”)Biomaterials2008254
27A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted DevicesJACC: Heart Failure2017248
28Successful Management of Benign Biliary Strictures With Fully Covered Self-Expanding Metal StentsGastroenterology2014234
29Early Procedural and Health Status Outcomes After Chronic Total Occlusion AngioplastyJACC: Cardiovascular Interventions2017234
30Transcatheter Aortic Valve Replacement for Severe Symptomatic Aortic Stenosis Using a Repositionable Valve SystemJournal of the American College of Cardiology2014230
31Carotid stenting with distal protection in high surgical risk patients: The BEACH trial 30 day resultsCatheterization and Cardiovascular Interventions2006227
32Efficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary StentCirculation: Cardiovascular Interventions2015222
33Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY StudyHepatology2021215
34Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE)Lancet, The2015214
35Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial FibrillationJournal of the American College of Cardiology2017214
36Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure DeviceCirculation2021208
37Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure TechnologyCirculation: Arrhythmia and Electrophysiology2019199
38A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trialLancet, The2018196
39Women’s Participation in Cardiovascular Clinical Trials From 2010 to 2017Circulation2020195
40A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary StentJournal of the American College of Cardiology2011193
41Primary Endpoint Results of the EVOLVE TrialJournal of the American College of Cardiology2012188
42Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus documentEuropean Journal of Heart Failure2013182
43Machine learning‐based phenogrouping in heart failure to identify responders to cardiac resynchronization therapyEuropean Journal of Heart Failure2019175
44Impact of Post-Intervention Minimal Stent Area on 9-Month Follow-Up Patency of Paclitaxel-Eluting StentsJACC: Cardiovascular Interventions2009173
45Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart FailureCirculation2009159
46The Taxus™ drug-eluting stent: A new paradigm in controlled drug deliveryAdvanced Drug Delivery Reviews2006158
47A simplified in vivo approach for evaluating the bioabsorbable behavior of candidate stent materialsJournal of Biomedical Materials Research - Part B Applied Biomaterials2012158
48Relationship between angiographic late loss and target lesion revascularization after coronary stent implantationJournal of the American College of Cardiology2005149
49Survival After Shock Therapy in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy-Defibrillator Recipients According to Rhythm ShockedJournal of the American College of Cardiology2013147
50Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label studyLancet Neurology, The2015142